One of these mechanisms is based upon the inhibition of the secretion of autocrine/paracrine IGF-I or IGF-II from the tumours, while probably the most important pathway involves the blockade of action of autocrine GHRH in tumours. This evidence concerns the gene IGF2 and neoplasm.